Comparison of Two Stapled Antimesenteric Anastomosis for CD: a Randomized Control Trial Study

Last updated: December 17, 2022
Sponsor: Jinling Hospital, China
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT05658081
jinlingH20221202
  • Ages 16-60
  • All Genders

Study Summary

The postoperative recurrence of Crohn's diseases (CD) remains high. Stapled anti-mesenteric functional end-to-end anastomosis was safe for CD patients. Its impact on the postoperative recurrence of CD was unknown. Whether it is superior than the conventional anastomosis (stapled antimesenteric isoperistaltic side-to-side anastomosis) needs explored. The trial aims to compare the different impacts of the two antimesenteric anastomosis configurations on the anastomotic recurrence following bowel resection.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • patients with Crohn's disease needing bowel resection and anastomosis;
  • ileocolic anastomosis；
  • written consent acquired

Exclusion

Exclusion Criteria:

  • patients underwent enterostomy;
  • small bowel anastomosis;
  • anticipating other trial.

Study Design

Total Participants: 236
Study Start date:
December 08, 2022
Estimated Completion Date:
December 31, 2029

Connect with a study center

  • Department of General Surgery, Jinling hosptal,Medical School of Nanjing University

    Nanjing, Jiangsu 210002
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.